During the past decade, Kardiologijos ir reabilitacijos klinika, UAB conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kardiologijos ir reabilitacijos klinika, UAB" are "Atherosclerotic Cardiovascular Disease" (1 trials) and "Coronary Heart Disease (CHD)" (1 trials). Many other conditions were trialed in "Kardiologijos ir reabilitacijos klinika, UAB" in a lesser frequency.

Most popular intervention types in "Kardiologijos ir reabilitacijos klinika, UAB" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Evolocumab" (1 trials), "Lp(a) Screening" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kardiologijos ir reabilitacijos klinika, UAB" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kardiologijos ir reabilitacijos klinika, UAB". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kardiologijos ir reabilitacijos klinika, UAB, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kardiologijos ir reabilitacijos klinika, UAB, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".